DEDD2 (death effector domain containing 2) is a nuclear-localized protein that plays a critical role in death receptor-mediated apoptosis through its death effector domain (DED). DEDD2 functions as a potent inducer of apoptosis in various cell types, with both its N-terminal DED domain and C-terminal region contributing to this pro-apoptotic activity 1. The protein's mechanism involves binding to caspase-8 and caspase-10, facilitating their translocation to the nucleus during CD95-induced apoptosis 1. DEDD2 requires nuclear localization through a bipartite nuclear localization signal for its pro-apoptotic function and specifically sensitizes cells to extrinsic apoptotic signals triggered by Fas, TRAIL, or FADD, while not affecting intrinsic pathways 2. The protein also interacts with c-FLIP and can form homo- and heterodimeric complexes with DEDD 12. Beyond apoptosis regulation, DEDD2 has emerged as a prognostic biomarker in multiple cancers, including bladder cancer and glioblastoma multiforme, where its expression correlates with patient survival outcomes and immune infiltration patterns 34. The protein may also participate in RNA processing and transcriptional regulation based on its nuclear localization and associated gene ontology annotations.